Romano Brothers AND Company Sells 4,812 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Romano Brothers AND Company reduced its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 18.7% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 20,975 shares of the pharmacy operator’s stock after selling 4,812 shares during the period. Romano Brothers AND Company’s holdings in Walgreens Boots Alliance were worth $188,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of WBA. First Trust Direct Indexing L.P. boosted its position in shares of Walgreens Boots Alliance by 1.9% during the first quarter. First Trust Direct Indexing L.P. now owns 32,085 shares of the pharmacy operator’s stock worth $696,000 after buying an additional 597 shares during the period. FinTrust Capital Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 60.4% during the 1st quarter. FinTrust Capital Advisors LLC now owns 2,130 shares of the pharmacy operator’s stock worth $46,000 after acquiring an additional 802 shares in the last quarter. Redwood Investment Management LLC raised its holdings in shares of Walgreens Boots Alliance by 0.9% in the first quarter. Redwood Investment Management LLC now owns 99,661 shares of the pharmacy operator’s stock valued at $2,162,000 after purchasing an additional 850 shares during the last quarter. Empirical Finance LLC grew its stake in shares of Walgreens Boots Alliance by 3.5% in the first quarter. Empirical Finance LLC now owns 26,093 shares of the pharmacy operator’s stock valued at $566,000 after buying an additional 888 shares in the last quarter. Finally, Inlet Private Wealth LLC increased its holdings in Walgreens Boots Alliance by 1.9% during the second quarter. Inlet Private Wealth LLC now owns 47,820 shares of the pharmacy operator’s stock worth $578,000 after buying an additional 900 shares during the last quarter. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $9.34 on Friday. The stock’s fifty day moving average price is $9.37 and its two-hundred day moving average price is $12.91. The firm has a market cap of $8.08 billion, a PE ratio of -0.93, a price-to-earnings-growth ratio of 1.24 and a beta of 0.70. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter in the previous year, the firm earned $0.67 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.9% compared to the same quarter last year. As a group, research analysts expect that Walgreens Boots Alliance, Inc. will post 1.57 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be paid a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 10.71%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -9.99%.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Jefferies Financial Group dropped their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday. Morgan Stanley decreased their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a report on Friday, October 11th. UBS Group raised their price target on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. TD Cowen dropped their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday. Finally, Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research note on Monday, October 7th. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.